Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 407 participants.
Also called NCT01182441
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 407 participants
- Sponsor
- Registry
-
NCT01182441
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01182441. Randomized; no masking; primary purpose treatment. Start 2010-11 (actual); primary completion 2013-01 (actual). Results posted on 2018-07-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
- Acronym
- PREVAIL
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Intervention (Device)
- WATCHMAN Device
- Intervention (Drug)
- Warfarin
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct01182441- Content hash
32f1b7dec340c07ae65c80044f3a60fbf4edf7b82944ef19847520295c8c5062